Enanta Pharmaceuticals, Inc. (ENTA)

14.72 +1.22 (+9.08%) USD  |  NASDAQ  |  Feb 24, 13:50
More

Enanta Pharmaceuticals Cash from Other Financing Activities (Quarterly)

Cash from Other Financing Activities (Quarterly) Chart

View Cash from Other Financing Activities (Quarterly) for ENTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Other Financing Activities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Other Financing Activities (Quarterly) Benchmarks

View Cash from Other Financing Activities (Quarterly) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. --
BioMarin Pharmaceutical, Inc. Upgrade